Implementation of the Smoking Treatment and Recovery (STAR) program: healthy cancer survivorship through integrated tobacco control
Tóm tắt
It is well-established that persistent tobacco use among patients with cancer results in numerous adverse outcomes. However, the assessment and treatment of tobacco use with evidence-based methods have been lacking in cancer care. Our cancer center has established its first tobacco treatment program, a multidisciplinary, evidence-based, clinical program for hematology/oncology patients. We describe the development and implementation of the program, emphasizing lessons learned in treating nicotine addiction among patients who are at very high risk for continuing to use tobacco throughout the survivorship phase. We developed a system to assess tobacco use at each outpatient visit, from those recently diagnosed to long-term survivors. For patients who have smoked in the past month, the protocol offers standard behavioral and pharmacological treatments, delivered by tobacco treatment specialists and nurse practitioners over four in-person and/or telephone-based sessions. Partnerships with the Psychosocial Oncology and Cancer Survivorship Programs have provided integrated and comprehensive care for patients during and after their cancer treatment. The systematic efforts to reach and engage current smokers have laid the groundwork for maximizing the program’s future effectiveness and impact. Our initial results demonstrate not only the complexities but also the feasibility of developing a new tobacco treatment program in the oncology setting. The implications for cancer survivors are the significant improvements in treatment outcomes that occur with tobacco abstinence.
Tài liệu tham khảo
U.S. Department of Health and Human Services. The health consequences of smoking: 50 years of progress: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
Gallaway M, Glover-Kudon R, Momin B, Puckett M, Lunsford NB, Ragan K, et al. Smoking cessation attitudes and practices among cancer survivors- United States, 2015. J Ca Surviv. 2019;13(1):66–74.
Croyle RT, Morgan GD, Fiore MC. Addressing a core gap in cancer care- The NCI Moonshot program to help oncology patients stop smoking. N Engl J Med. 2019;380(6):512–5.
Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, et al. Research priorities, measures, and recommendations for assessment of tobacco use in clinical cancer research. Clin Cancer Res. 2016;22(8):1907–13.
Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103(6):e38–46.
Karam-Hage M, Oughli HA, Rabius V, Beneventi D, Wippold RC, Blalock JA, et al. Tobacco cessation treatment pathways for patients with cancer: 10 years in the making. J Natl Compr Cancer Netw. 2016;14(11):1469–77.
Warren GW, Ward KD. Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. Transl Lung Cancer Res. 2015;4(4):339–52.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Distress Management. Version 2.2018. https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf Accessed 10/12/19.
Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hysert P, et al. Automated tobacco assessment and cessation support for cancer patients. Cancer. 2014;120(4):562–9.
Antwi GO, Lohrmann DK, Jayawardene W, Chow A, Obeng CS, Sayegh AM. Associations between e-cigarette and combustible cigarette use among U.S. cancer survivors: implications for research and practice. J Cancer Surviv. 2019;13(2):316–25.